114 results
Page 3 of 6
8-K
EX-99.2
fk7 4xvsdbxrpl40b
11 Jun 21
Other Events
7:24am
8-K
EX-99.1
fb3t8fkcf
29 Apr 21
Agios Reports Business Highlights and First Quarter 2021 Financial Results
7:28am
8-K
EX-99.1
rsdvo dayo7jf6yuz1
25 Feb 21
Agios Reports Fourth Quarter and Full Year 2020 Financial Results
7:17am
DEFM14A
hz56q 0wm1
11 Feb 21
Proxy related to merger
4:19pm
PREM14A
eysxad60 8al9d35l4we
29 Jan 21
Preliminary proxy related to merger
4:22pm
8-K
EX-99.1
284ey512rd
26 Jan 21
Other Events
4:14pm
DEFA14A
jo5azxr7 mkv4
12 Jan 21
Additional proxy soliciting materials
5:15pm
DEFA14A
zjxghvzfbdm5u7s9
11 Jan 21
Additional proxy soliciting materials
7:17am
8-K
EX-99.1
zu40h lbio4j69hs9
11 Jan 21
Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term Value Creation
7:14am
DEFA14A
EX-99.2
wrxxbsljkj4gu5
21 Dec 20
Additional proxy soliciting materials
7:10am
8-K
EX-99.2
cjnrce0sx5q4o 30bt
21 Dec 20
Regulation FD Disclosure
7:04am
8-K
EX-99.1
8e4oa4yv
7 Dec 20
Agios Announces Updated Data from Phase 1 Study of Mitapivat, First-in-Class PKR Activator, in Sickle Cell Disease
4:53pm
8-K
EX-99.1
ai8sylb0
1 Dec 20
Other Events
7:46am
8-K
EX-99.1
pgcuyx
5 Nov 20
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
7:32am
8-K
EX-99.1
db6xcz 7o
21 Sep 20
Other Events
7:14am
8-K
EX-99.1
80fgvvvlyr
8 Sep 20
Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs
4:09pm
8-K
EX-99.1
eo5hpw o3o
30 Jul 20
Agios Reports Business Highlights and Second Quarter 2020 Financial Results
7:17am